CME Symposium- Narcolepsy and Excessive Daytime Sleepiness in Obstructive Sleep Apnea: Strategies to Improving Outcomes

SPRINGFIELD, N.J. - April 3, 2019 - PRLog -- Register online now
Obstructive sleep apnea (OSA) and narcolepsy are sleep disorders associated with high prevalence and symptomatic burden including prominent sleepiness, daytime dysfunction, and poor nocturnal sleep.  Both have an elevated risk for adverse health outcomes. Narcolepsy is a debilitating disease with substantial clinical and socioeconomic burden resulting from its early onset, severe symptoms, delay in diagnosis, lack of cure, and a need for life-long therapy. This need for lifelong therapy, in particular, requires the establishment of health care policies that shorten the time to finding an effective treatment plan. Appropriate treatment results in long-term benefits from both patient and societal perspectives by improving clinical outcomes, potentially enabling improved education and increased employment and work productivity, and quality of life.  Residual daytime sleepiness despite the use of continuous positive airway pressure (CPAP) is a long-standing clinical dilemma.  Identifying the cause of the excessive daytime sleepiness (EDS) requires a comprehensive evaluation by the clinician and effective communication with the patient.  Management of narcolepsy and EDS in individuals with OSA involves the use of nonpharmacologic and pharmacologic strategies; new therapies, as well new indications for established agents, are changing the therapeutic landscape.  In this program, chair Dr. Richard Bogan and faculty members Dr. Yves Dauvilliers, Dr. Kiran Maski, Dr. Paula Schweitzer, and Dr. Michael Thorpy will describe the clinical and socioeconomic burden of narcolepsy and discuss strategies to address its burden, explain best practices for determining the cause of EDS in OSA patients, and assess traditional and new therapies for treating patients with narcolepsy and EDS in OSA.
Register online now
Chair:
Richard Bogan, MD
Associate Clinical Professor
University of South Carolina School of Medicine
Columbia, South Carolina

Faculty:

Yves Dauvilliers, MD, PhD
Professor of Neurology
University of Montpellier
Montpellier, France

Kiran Maski, MD, MPH
Assistant Professor of Neurology
Harvard Medical School
Boston, Massachusetts

Paula Schweitzer, PhD
Director of Research
Sleep Medicine & Research Center
Chesterfield, Missouri

Michael Thorpy, MD
Professor of Neurology
Albert Einstein College of Medicine
Bronx, New York

Voxmedia LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Voxmedia LLC designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.

The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.

Voxmedia International gratefully acknowledges the educational grant provided by Jazz Pharmaceuticals, Inc.

This educational activity is intended for physicians and other healthcare professionals involved in the management of sleep disorders.

Pre-registration is for planning purposes only.

For additional CME activities and online cme courses visit CMEPlanet